RGNX
Regenxbio Inc

2,495
Loading...
Loading...
News
all
press releases
SNY's Gene Therapy Candidate for Eye Disease Gets FDA Fast Track Tag
Sanofi's gene therapy SAR402663 for wet AMD earns FDA fast track status, aiming to speed up development and reduce treatment burden.
Zacks·5d ago
News Placeholder
More News
News Placeholder
Are Options Traders Betting on a Big Move in Regenxbio Stock?
Investors need to pay close attention to RGNX stock based on the movements in the options market lately.
Zacks·1mo ago
News Placeholder
Regenxbio (RGNX) Reports Q2 Loss, Lags Revenue Estimates
Regenxbio (RGNX) delivered earnings and revenue surprises of -22.12% and -21.16%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Aligos Therapeutics, Inc. (ALGS) Reports Q2 Loss, Misses Revenue Estimates
Aligos Therapeutics (ALGS) delivered earnings and revenue surprises of +34.89% and -3.50%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Regenxbio (RGNX) Q1 Earnings and Revenues Lag Estimates
Zacks·4mo ago
News Placeholder
Biotech stocks jump as Makary outlines FDA vision, RBC comments
Investing.com -- Biotech stocks climbed Monday after new FDA Commissioner Dr. Marty Makary laid out a clear and collaborative regulatory strategy that analysts say bodes well for drug developers. In his first major interview since taking office, Makary emphasized pragmatic reforms, faster drug approvals, and modernized use of real-world data across the agency.
investing.com·5mo ago
News Placeholder
REGENXBIO to Participate in Upcoming Investor Conferences
REGENXBIO to Participate in Upcoming Investor Conferences REGENXBIO to Participate in Upcoming Investor Conferences PR Newswire ROCKVILLE, Md., Feb. 25, 2025 ROCKVILLE, Md., Feb. 25, 2025...
PR Newswire·7mo ago
News Placeholder
REGENXBIO Announces Presentations of RGX-121 at the 21st Annual WORLDSymposium 2025
REGENXBIO Announces Presentations of RGX-121 at the 21st Annual WORLDSymposium 2025 REGENXBIO Announces Presentations of RGX-121 at the 21st Annual WORLDSymposium 2025 PR Newswire ROCKVILLE, Md...
PR Newswire·8mo ago
News Placeholder
REGENXBIO and Nippon Shinyaku Announce Exclusive Partnership to Develop and Commercialize RGX-121 and RGX-111 for MPS Diseases
REGENXBIO and Nippon Shinyaku Announce Exclusive Partnership to Develop and Commercialize RGX-121 and RGX-111 for MPS Diseases REGENXBIO and Nippon Shinyaku Announce Exclusive Partnership to Develop...
PR Newswire·8mo ago
News Placeholder
AbbVie and REGENXBIO Announce Updates on the ABBV-RGX-314 Clinical Program
AbbVie and REGENXBIO Announce Updates on the ABBV-RGX-314 Clinical Program AbbVie and REGENXBIO Announce Updates on the ABBV-RGX-314 Clinical Program PR Newswire NORTH CHICAGO, Ill. and ROCKVILLE...
PR Newswire·8mo ago

Latest RGNX News

View

Advertisement. Remove ads.

Advertisement. Remove ads.